Link: https://bmcmedinformdecismak.biomedcentral.com/articles/10.1186/s12911-020-1105-4 Background It is of utmost importance to investigate novel therapies for cancer, as it is a major cause of death. In recent years, immunotherapies, especially those against immune checkpoints, have been developed and brought significant improvement in cancer management. However, on the other hand, immune checkpoints blockade (ICB) by monoclonal antiboties may causeContinueContinue reading “The lab publishes a new work in BioNLP & “Phenotype research””
-
Subscribe
Subscribed
Already have a WordPress.com account? Log in now.
Jingbo's BioNLP Lab 